Patents by Inventor Raymond Alan Grant

Raymond Alan Grant has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BIFIDOBACTERIUM LONGUM ABLE TO BENEFICIALLY MODULATE IMMUNE RESPONSE TO RESPIRATORY VIRUS INFECTION
    Publication number: 20200016220
    Abstract: Bifidobacterium longum strains and cell wall fractions isolated from Bifidobacterium longum strains are useful in the prophylaxis or treatment of a respiratory viral infection in a subject. They are also useful in the prophylaxis of a secondary bacterial infection associated with a respiratory viral infection in a subject, especially a subject who is susceptible to respiratory infections.
    Type: Application
    Filed: February 28, 2018
    Publication date: January 16, 2020
    Applicant: Alimentary Health Limited
    Inventors: Barry KIELY, Liam O'MAHONY, David GROEGER, Raymond Alan GRANT, David MICHALOVICH, Edith M. HESSEL, Richard A. WILLIAMSON
  • NONINVASIVE METHOD FOR MEASURING OXIDATIVE STRESS AND OXIDATIVE DAMAGE FROM SKIN: OXIDATIVE STRESS AND OXIDATIVE DAMAGE BIOMARKERS
    Publication number: 20140273055
    Abstract: A noninvasive method for diagnosing skin health in a subject comprising collecting a skin sample/epithelial cell sample from the subject; detecting a level of one or more biomarkers selected from the group consisting of Myeloperoxidase and oxidized lipids in the epithelial cell sample/skin cell sample; diagnosing the subject as having oxidative stress and/or oxidative damage based on the level of a detected biomarker. Further, a noninvasive method for evaluating the efficacy of products for skin health.
    Type: Application
    Filed: March 14, 2014
    Publication date: September 18, 2014
    Applicant: The Procter & Gamble Company
    Inventors: Kathleen Marie KERR, Angela Marie FIENO, Kenneth Robert WEHMEYER, Lijuan LI, James Robert SCHWARTZ, Raymond Alan GRANT
  • NONINVASIVE METHOD FOR MEASURING ANTIMICROBIAL PEPTIDES FROM SKIN AS AN OBJECTIVE MEASUREMENT OF NATURAL PROTECTION FROM MICROBES
    Publication number: 20140273065
    Abstract: A noninvasive method for measuring skin health in a subject comprising collecting an epithelial cell/skin cell sample from the subject; detecting a level of one or more antimicrobial peptide biomarkers in the epithelial cell sample/skin cell sample; diagnosing the subject as having a defense mechanism due to microbial attack on skin or a measure of the system being in balance with environment homeostasis based on the level of one or more antimicrobial peptide biomarkers selected from the group consisting of Histone H2B type 1-M, Histone H2A, Histone H4, Protein S100-A7, Protein S100-A8, Protein S100-A9, Cathepsin G, Neutrophil defensin 3 (Defensin, alpha 3) (HNP-3), Dermcidin, Ribonuclease 7 (RNase 7), human beta-defensin -2 (nBD-2) and Beta-defensin 103 (hBD-3) and listed in Table 1 wherein the AMP families include bactericidal permeability-increasing protein (BPI), Defensin, Histone, Pore-forming toxin, S100 protein, Cytotoxin, Serine Protease 51, Dual Oxidase, transcription regulation, and mixtures thereof
    Type: Application
    Filed: March 14, 2014
    Publication date: September 18, 2014
    Applicant: The Procter & Gamble Company
    Inventors: Kathleen Marie KERR, Angela Marie FIENO, Yiping NMN SUN, Tanuja NMN CHAUDHARY, Raymond Alan GRANT, Kevin John MILLS
  • EXOPOLYSACCHARIDE
    Publication number: 20130261071
    Abstract: An isolated polysaccharide has the structure [-?(1,3)-D-GaIpNAc-?(1,4)-D-Glcp-]n. The polysaccharide may be from a Bifidobacterium strain NCIMB 41003. The polysaccharide exhibits immunomodulatory activity.
    Type: Application
    Filed: January 10, 2013
    Publication date: October 3, 2013
    Applicants: Alimentary Health, Limited, THE PROCTER & GAMBLE COMPANY
    Inventors: Raymond Alan GRANT, Liam OMAHONY, Barbara SHEIL
  • Exopolysaccharide
    Patent number: 8357794
    Abstract: An isolated polysaccharide has the structure [-?(1,3)-D-GalpNAc-?(1,4)-D-Glcp-]n The polysaccharide may be from a Bifidobacterium strain NCIMB41003. The polysaccharide exhibits immunomodulatory activity.
    Type: Grant
    Filed: May 2, 2008
    Date of Patent: January 22, 2013
    Assignee: The Procter & Gamble Company and Alimentary Health Limited
    Inventors: Raymond Alan Grant, Liam O'Mahony, Barbara Sheil
  • EXOPOLYSACCHARIDE
    Publication number: 20110046084
    Abstract: An isolated polysaccharide has the structure [-?(1,3)-D-GalpNAc-?(1,4)-D-Glcp-]n The polysaccharide may be from a Bifidobacterium strain NCIMB41003. The polysaccharide exhibits immunomodulatory activity.
    Type: Application
    Filed: May 2, 2008
    Publication date: February 24, 2011
    Inventors: Raymond Alan Grant, Liam O'mahony, Barbara Sheil